alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED
CONSOLIDATED BALANCE SHEET - UNAUDITED AND CONDENSED CONSOLIDATED STATEMENT OF
INCOME AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1996
<PERIOD-END>                                   DEC-31-1996
<CASH>                                         37,387
<SECURITIES>                                   39,558
<RECEIVABLES>                                  15,598
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               92,957
<PP&E>                                         7,686
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 111,704
<CURRENT-LIABILITIES>                          19,957
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       7
<OTHER-SE>                                     90,806
<TOTAL-LIABILITY-AND-EQUITY>                   111,704
<SALES>                                        0
<TOTAL-REVENUES>                               88,920
<CGS>                                          18,463
<TOTAL-COSTS>                                  73,173
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                18,449
<INCOME-TAX>                                   7,635
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   10,814
<EPS-BASIC>                                  0.16
<EPS-DILUTED>                                  0.14


</TABLE>
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**10 CA 16-01146**  PRESENT: CENTRA, J.P., PERADOTTO, CARNI, AND LINDLEY, JJ.

THE CANANDAIGUA NATIONAL BANK AND TRUST COMPANY, PLAINTIFF-RESPONDENT,

V ORDER

MATTHEW PALMER, ALSO KNOWN AS MATTHEW J. PALMER, PALMER AUTOMOTIVE, INC., DEFENDANTS-APPELLANTS, ET AL., DEFENDANTS.

CHENEY & BLAIR, LLP, GENEVA (DAVID D. BENZ OF COUNSEL), FOR DEFENDANTS-APPELLANTS.

HARTER SECREST & EMERY LLP, ROCHESTER (JESSICA A. MYERS OF COUNSEL), FOR PLAINTIFF-RESPONDENT.

Appeal from an order of the Supreme Court, Ontario County (Frederick G. Reed, A.J.), entered August 24, 2015. The order granted plaintiff’s motion for summary judgment.
It is hereby ORDERED that the order so appealed from is unanimously affirmed without costs.

Entered: February 3, 2017 Frances E. Cafarell Clerk of the Court
Exhibit 23.0

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by
reference in the Registration Statement on Form S-8 (No.333-138651) and Registration Statement on Form S-3 (No.333-64177) of our reports dated February 22, 2008, relating to Intervest Bancshares Corporation and Subsidiaries consolidated
financial statements and its internal control over financial reporting, included in this Annual Report on Form 10-K for the year ended December 31, 2007.



|                                       
|---------------------------------------
|/s/ Hacker, Johnson & Smith, P.A., P.C.
|Hacker, Johnson & Smith, P.A., P.C.    
|Tampa, Florida                         
|February 22, 2008
#### The People of the State of New York, Respondent, v Alfred George, Appellant.

[987 NYS2d 459]

Appeal by the defendant from an order of the Supreme Court, Queens County (Kohm, J.), dated January 24, 2013, which, after a hearing, denied his motion for resentencing pursuant to CPL 440.46 on his conviction of criminal sale of a controlled substance in the third degree, which sentence was originally imposed by the same court (Pitaro, J.), upon a jury verdict, on July 10, 1996.

Ordered that the order is affirmed.

Under the circumstances of this case, the Supreme Court did not improvidently exercise its discretion in denying the defendant’s motion to be resentenced pursuant to CPL 440.46. The defendant has a very extensive criminal history, which includes three felonies, 16 misdemeanors, and eight violations *(see People v Vidal,*111 AD3d 967, 968 [2013]; *People v Browne,*107 AD3d 1013 [2013]; *People v Milland,*103 AD3d 669, 670 [2013]). Further, he has violated conditions of parole on at least 10 occasions, and has exhibited a pattern of committing new crimes while on parole *(see People v Vidal,*111 AD3d at 968; *People v Browne,*107 AD3d at 1013; *People v Milland,*103 AD3d at 670; *People v Avila,*84 AD3d 1259, 1260 [2011]). Indeed, while a prior motion for resentencing pursuant to CPL 440.46 was pending before the Supreme Court, the defendant committed an additional crime. On several occasions while on parole, the defendant failed to participate in or absconded from substance abuse treatment programs. In addition, his institutional record of confinement shows two tier II infractions. Accordingly, substan*1020tial justice dictated that the defendant’s motion be denied *(see People v Vidal,*111 AD3d at 968; *People v Gonzalez,*96 AD3d 875, 876 [2012]).

Rivera, J.E, Balkin, Dickerson and Cohen, JJ., concur.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel; NIDA Medications Development.                    

*Date:*                         November 1, 2017.                    

*Time:*                         8:00 a.m. 5:00 p.m.                    

*Agenda:*                         To review and evaluate cooperative agreement applications.                    

*Place:*                         Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814.                    

*Contact Person:*                         Ivan K. Navarro, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, Room 4242, MSC 9550, Bethesda, MD 20892, 301-827-5833,                         *ivan.navarro@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

Dated: October 10, 2017.

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-22247 Filed 10-13-17; 8:45 am]

 BILLING CODE 4140-01-P
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr.

, Chief Justice

Stephen J. Markman

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

Joan L. Larsen,

Justices

I, Larry S. Royster , Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

June 1, 2016

a0525 

# Order

Clerk June 1, 2016

151549

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff

- Appellee,

v SC: 151549

COA: 325140

Presque Isle CC: 05

- 092269

- FC

GARY EDWARD DAVENPORT,

Defendant

- Appellant.

_____________________________________/

On order of the Court, the application for leave to appeal the March 12, 2015 order

of the Court of Appeals is considered, and it is DENIED, because th e defendant has

failed to meet the burden of establishing entitlement to relief under MCR 6.508(D).
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   6-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-1999
<PERIOD-START>                             JAN-01-2000             JAN-01-1999
<PERIOD-END>                               JUN-30-2000             JUN-30-1999
<CASH>                                           3,720                  17,299
<SECURITIES>                                    18,360                  19,906
<RECEIVABLES>                                   19,536                   9,979
<ALLOWANCES>                                       593                     493
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                44,141                  47,644
<PP&E>                                           5,793                   3,543
<DEPRECIATION>                                   2,383                   1,592
<TOTAL-ASSETS>                                 177,975                  51,822
<CURRENT-LIABILITIES>                           16,992                  10,595
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                       210,920                  71,900
<OTHER-SE>                                           0                       0
<TOTAL-LIABILITY-AND-EQUITY>                   177,975                  51,822
<SALES>                                         32,131                   8,668
<TOTAL-REVENUES>                                32,131                   8,668
<CGS>                                            7,603                   3,269
<TOTAL-COSTS>                                   45,186                  10,790
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                               (769)                    (49)
<INCOME-PRETAX>                               (19,889)                 (5,342)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                           (19,889)                 (5,342)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                  (19,889)                 (5,342)
<EPS-BASIC>                                     (0.83)                  (1.12)
<EPS-DILUTED>                                   (0.83)                  (1.12)


</TABLE>
EX-10.14



 EXHIBIT 10.14 

Acknowledgement and Waiver Agreement 

between 
  

	1.	PIERIS AG, Lise-Meitner-Straße 30, 85354 Freising-Weihenstephan, represented by its Supervisory Board 


- hereinafter referred to as the “Company” - 
  

	2.	Stephen S. Yoder, Poccistr. 11, 85375 Neufahrn b. Freising 

 - hereinafter referred
to as the “CEO” - 
 - Company and CEO herein collectively also referred to as the “Parties” – 

The Parties have concluded a management agreement on 30 August 2009 as amended on March 12, 2012 (the “Management Agreement”). Pursuant to
clause 4.3 of the Management Agreement, the CEO shall be eligible to participate in the option pool in such way that the CEO shall be granted a stake of 2.5 % in the Company in an event of a sale of the shares in the Company or a sale of the
assets of the Company. 
 The Company intends to enter into an acquisition agreement with Marika Inc. (to be renamed Pieris Pharmaceuticals, Inc.) and the
holders of 100% of the outstanding shares of the Company’s capital stock (the “Shareholders”), by which, inter alia, the Shareholders (a) contribute, transfer, assign and deliver all of their shares in the Company to Marika
Inc. in exchange for shares of common stock in Marika Inc. with the result of the Company becoming a wholly-owned subsidiary of Pieris Pharmaceuticals, Inc. (f/k/a, Marika Inc.) (the “Transaction”). 

Hereby, the Parties expressly acknowledge and agree that the Transaction (i) shall not be deemed as the Exit within the meaning of clause 4.3 of the
Management Agreement, based on the Parties’ original intention and understanding at the time they entering into the Management Agreement, and therefore, (ii) shall not result in a granting of the Exit Fee within the meaning of such clause 4.3.
For the avoidance of doubt, the CEO waives any such claims, in connection with the Transaction, under clause 4.3 of the Management Agreement, and the Company accepts this waiver. 

This Waiver Agreement shall be governed exclusively by German law. 
  

									
	 Freising, 2 December 2014
	 		 	München, 12 December 2014	 	
				
	 PIERIS AG
	 		 	STEPHEN S. YODER	 	
				
	 /s/ Chau Khuong
	 		 	 /s/ Stephen S. Yoder
	 	
					
	By:	 	Khuong, Chau	 		 		 	
					
	Its:	 	Chairman of the Supervisory Board	 		 		 	

 PIERIS AG _Stephen S. Yoder
NOTICE OF APPEARANCE OF LEAD APPELLATE COUNSEL FOR APPELLEES Page 1

D/977919v1

NO. 02-17-00429-CV

IN THE COURT OF APPEALS

FOR THE SECOND DISTRICT OF TEXAS

AT FORT WORTH, TEXAS

ABDIEL LOPEZ,

Appellant,

v.

CREST GATEWAY, L.P. AND CREST ASSET

MANAGEMENT, INC.,

Appellees.

On Appeal from the 96th District Court, Tarrant County, Texas

Cause No. 096-279371-15

(Hon. R. H. Wallace, Jr.)

NOTICE OF APPEARANCE OF

LEAD APPELLATE COUNSEL FOR APPELLEES

_________________________________________________________________

TO THE HONORABLE JUSTICES

OF THE FORT WORTH COURT OF APPEALS:

PLEASE TAKE NOTICE, pursuant to rule 6.2 of the Texas Rules of

Appellate Procedure, that Michelle E. Robberson, of the law firm of Cooper &

Scully, P.C., will serve as lead appellate counsel for Appellees Crest Gateway, L.P.

and Crest Asset Management, Inc. in the above-styled appeal, in addition to

Appellees’ trial counsel, Gordon K. Wright and John C. Faubion of Cooper &

Scully, P.C.

ACCEPTED

02-17-00429-CV

SECOND COURT OF APPEALS

FORT WORTH, TEXAS

12/20/2017 9:56 AM

DEBRA SPISAK

CLERK

 FILED IN 2nd COURT OF APPEALS FORT WORTH, TEXAS 12/20/2017 9:56:46 AM DEBRA SPISAK Clerk
NOTICE OF APPEARANCE OF LEAD APPELLATE COUNSEL FOR APPELLEES Page 2

D/977919v1

Contact information for Appellees’ lead appellate counsel is:

Michelle E. Robberson

Texas Bar No. 16982900

Cooper & Scully, P.C.

900 Jackson Street, Suite 100

Dallas, Texas 75202

(214) 712-9500

(214) 712-9540 (fax)

michelle.robberson@cooperscully.com

Ms. Robberson requests the Court and opposing parties and counsel add her to the

list of counsel in this case who will receive notice and service of all pleadings,

notices, briefs, orders, and other communications from the Court and from

opposing parties and counsel.

Respectfully submitted,

COOPER & SCULLY, P.C.

By: /s/ Michelle E. Robberson

MICHELLE E. ROBBERSON

Texas State Bar No. 16982900

michelle.robberson@cooperscully.com

900 Jackson Street, Suite 100

Dallas, Texas 75202

Telephone: 214.712.9500

Facsimile: 214.712.9540

ATTORNEYS FOR APPELLEES

CREST GATEWAY, L.P. AND CREST

ASSET MANAGEMENT, INC.
NOTICE OF APPEARANCE OF LEAD APPELLATE COUNSEL FOR APPELLEES Page 3

D/977919v1

CERTIFICATE OF SERVICE

I hereby certify that I served a true and correct copy of this Notice on the

counsel of record listed below via e-file on this 20th day of December, 2017:

Via E-filing

Domingo A. Garcia, garciadtx@aol.com

Ryan C. Sorrells, rsorrells@dgley.com

LAW OFFICES OF DOMINGO A. GARCIA, P.C.

600 Bank of America Tower-Oak Cliff

400 S. Zang Blvd.

Dallas, TX 75208

/s/ Michelle E. Robberson _____________

MICHELLE E. ROBBERSON
**EXHIBIT  32.1**

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THESARBANES-OXLEY ACT OF 2002

In connection with theQuarterly Report of NextMart, Inc. (the “Company”) on Form 10-QSB for thequarter ended June 30, 2007 as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Ren Huiliang, Chief ExecutiveOfficer of the Company, certify, pursuant to 18 U.S.C. §1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.       TheReport fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Act of 1934; and

2.       Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.
| /s/ Ren Huiliang                      |   |
|---------------------------------------|--------|
| Ren Huiliang, Chief Executive Officer |   |
| Date: August 20, 2007                 |   |

 

----
#### In re Folker LIEB, Hermann Hagemann, Arno Widdig, Michael Ruther, Reiner Fischer, Thomas Bretschneider, Christoph Erdelen, Ulrike Wachendorrf-Neumann, Peter Dahmen, Markus Dollinger, Hans-Joachim Santel, Alan Graff, Wolfram Andersch, Norbert Mencke, and Andreas Turberg (Real Party in Interest Bayer AG).

No. 2011-1076.

United States Court of Appeals, Federal Circuit.

June 9, 2011.

Mark D. Marin, Norris McLaughlin & Marcus, P.A., of New York, NY, argued for appellant.

Farheena Y. Rasheed, Associate Solicitor, United States Patent and Trademark Office, of Alexandria, Virginia, argued for appellee. With her on the brief were Raymond T. Chen, Solicitor and Janet A. Gon-gola, Associate Solicitor.

BRYSON, LINN, and O’MALLEY, Circuit Judges.

JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. *See*Fed. Cir. R. 36.
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 00-50569

Conference Calendar

 

JACINTO ARZATE-CORNEJO,

Petitioner-Appellant,

versus

R. D. MILES, Warden,

Respondent-Appellee.

- - - - - - - - - -

Appeal from the United States District Court

for the Western District of Texas

USDC No. A-99-CV-471-SS

- - - - - - - - - -

December 13, 2000

Before DAVIS, STEWART, and PARKER, Circuit Judges. 

PER CURIAM:*

Jacinto Arzate-Cornejo, federal prisoner # 91427-011,

appeals from the denial of his petition for writ of habeas corpus

pursuant to 28 U.S.C. § 2241. Arzate-Cornejo argues that he has

not received all the credit that he is due toward his federal

sentence. Under 18 U.S.C. § 3585(b), Arzate-Cornejo may be

awarded credit toward his term of imprisonment for any time he

spent in official detention prior to the commencement of his

sentence that was not credited against another sentence. Because

Arzate-Cornejo received credit toward his state sentence during
No. 00-50569

-2-

this period, he may not receive credit toward his federal

sentence. Accordingly, the judgment of the district court is

AFFIRMED.
EXHIBIT 32.5

                            CERTIFICATION PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

I, Patrick J. Goodman,  Vice President and Treasurer of MidAmerican Funding, LLC
(the "Company"),  certify,  pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

     (1)  the Annual  Report on Form 10-K/A of the Company for the annual period
          ended  December  31,  2003  (the  "Report")  fully  complies  with the
          requirements of Section 13(a) or 15(d) of the Securities  Exchange Act
          of 1934 (15 U.S.C. 78m or 78o(d)); and

     (2)  the  information  contained  in the  Report  fairly  presents,  in all
          material respects, the financial condition and result of operations of
          the Company.


Dated:  March 3, 2004



                             /s/ Patrick J. Goodman
                             ----------------------------
                                 Patrick J. Goodman
                             Vice President and Treasurer
                               (chief financial officer)
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3119 Reported in Senate (RS)]

                                                       Calendar No. 205
111th CONGRESS
  1st Session
                                H. R. 3119

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 23, 2009

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

                            November 4, 2009

              Reported by Mr. Lieberman, without amendment

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
at 867 Stockton Street in San Francisco, California, as the ``Lim Poon 
                           Lee Post Office''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LIM POON LEE POST OFFICE.

    (a) Designation.--The facility of the United States Postal Service 
located at 867 Stockton Street in San Francisco, California, shall be 
known and designated as the ``Lim Poon Lee Post Office''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Lim Poon 
Lee Post Office''.
                                                       Calendar No. 205

111th CONGRESS

  1st Session

                               H. R. 3119

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
at 867 Stockton Street in San Francisco, California, as the ``Lim Poon 
                           Lee Post Office''.

_______________________________________________________________________

                            November 4, 2009

                       Reported without amendment
```